B
Bull
Bull · 25%MGRM
$6.90
Szenariopreis
$6.000
-0.108 (-1.80%)Zum Schluss
Loading chart…
- High
- 6.425
- Open
- 6.100
- VWAP
- 6.10
- Vol
- 1.78M
- Mkt Cap
- 65.56M
- Low
- 5.870
- Amount
- 10.84M
- EV/EBITDA, TTM
- -3.28
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
Bewertungskennzahlen
The current forward P/E ratio for Monogram Technologies Inc (MGRM) is -3.30, compared to its 5-year average forward P/E of -5.34.
Alphio AI Price Scenarios for MGRM
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Event-Zeitleiste
News
3.507-29NewsfilterMonogram Technologies Announces World's First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery
- 3.507-22Newsfilter
From Diagnosis to Surgery: How AI Tech Is Quietly Reshaping Healthcare Profits
7.007-19GlobenewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SONN, FCCO, MGRM on Behalf of Shareholders
7.007-16GlobenewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WAT, VBTX, MGRM on Behalf of Shareholders
8.507-14BenzingaZimmer Biomet To Lead Orthopedic Robotics With Monogram's AI Tech
MGRM FAQ — answered by Alphio AI
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.